FDA approves Cantharidin (YCANTH™,  Verrica Pharmaceuticals) for treatment of Molluscum Contagiosum. This is the first FDA approved treatment for Molluscum Read More..

Verrica Pharmaceuticals Inc. is a dermatology therapeutics company developing medications for skin diseases requiring medical interventions. In a statement, Ted White, Verrica’s President and Chief Executive Officer  said “We are proud to bring patients and caregivers the first FDA-approved treatment for molluscum, which is one of the largest unmet needs in medical dermatology,”. YCANTH (cantharidin) topical solution, 0.7% is indicated for the topical treatment of molluscum contagiosum in adult and pediatric patients 2 years of age and older. (Verrica Statement)

Cantharidin is an odorless, colorless fatty substance of the terpenoid class, which is secreted by many species of blister beetles.